Non-canonical actions of Nogo-A and its receptors

Biochem Pharmacol. 2016 Jan 15:100:28-39. doi: 10.1016/j.bcp.2015.08.113. Epub 2015 Sep 4.

Abstract

Nogo-A is a myelin associated protein and one of the most potent neurite growth inhibitors in the central nervous system. Interference with Nogo-A signaling has thus been investigated as therapeutic target to promote functional recovery in CNS injuries. Still, the finding that Nogo-A presents a fairly ubiquitous expression in many types of neurons in different brain regions, in the eye and even in the inner ear suggests for further functions besides the neurite growth repression. Indeed, a growing number of studies identified a variety of functions including regulation of neuronal stem cells, modulation of microglial activity, inhibition of angiogenesis and interference with memory formation. Aim of the present commentary is to draw attention on these less well-known and sometimes controversial roles of Nogo-A. Furthermore, we are addressing the role of Nogo-A in neuropathological conditions such as ischemic stroke, schizophrenia and neurodegenerative diseases.

Keywords: Cell signaling; Distribution; Neurodegenerative diseases; Nogo-A; Nogo-receptor; Regenerative medicine.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Brain / metabolism*
  • Brain / pathology
  • GPI-Linked Proteins / metabolism*
  • Glioma / metabolism
  • Glioma / pathology
  • Growth Inhibitors / metabolism
  • Humans
  • Multiple Sclerosis / metabolism
  • Multiple Sclerosis / pathology
  • Myelin Proteins / metabolism*
  • Myelin Sheath / metabolism
  • Myelin Sheath / pathology
  • Neurites / metabolism
  • Neurites / pathology
  • Neurons / metabolism
  • Neurons / pathology
  • Nogo Proteins

Substances

  • GPI-Linked Proteins
  • Growth Inhibitors
  • Myelin Proteins
  • Nogo Proteins
  • RTN4 protein, human